Abdallah Daar

Q: What Schools Are Affiliated With Abdallah Daar

Abdallah Daar is affiliated with the following schools: University of Oxford, University of Toronto, Sultan Qaboos University

Abdallah Daar's AcademicInfluence.com Rankings

Abdallah Daar

Medical

#1782

World Rank

#2158

Historical Rank

Surgery

#192

World Rank

#240

Historical Rank

Public Health

#422

World Rank

#436

Historical Rank

medical Degrees

Abdallah Daar

Philosophy

#4460

World Rank

#6979

Historical Rank

Logic

#6588

World Rank

#8119

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Abdallah Daar Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Dr. Abdallah Daar is an Emeritus Professor of Clinical Public Health, Global Health, and Surgery at the University of Toronto. He has also been a Senior Scientist at the Research Institutes of University Health Network/Toronto General Hospital Research Institute, and the Hospital for SickKids. At the University of Toronto Joint Centre for Bioethics, from 2001 to 2007, he was co-director of the Canadian Program on Genomics and Global Health, and Director of the University of Toronto Program in Applied Ethics and Biotechnology. At the Sandra Rotman Centre, he was Director of Ethics and Commercialization.

(See a Problem?)

Abdallah Daar's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Grand challenges in global mental health (2011) (1723)
Grand challenges in chronic non-communicable diseases (2007) (677)
THE DETAILED DISTRIBUTION OF MHC CLASS II ANTIGENS IN NORMAL HUMAN ORGANS (1984) (419)
THE DETAILED DISTRIBUTION OF HLA‐A, B, C ANTIGENS IN NORMAL HUMAN ORGANS (1984) (413)
Top ten biotechnologies for improving health in developing countries (2002) (355)
Grand Challenges in Global Health: Community Engagement in Research in Developing Countries (2007) (338)
Nanotechnology and the Developing World (2005) (320)
Grand Challenges in Global Health (2003) (258)
Ethics and SARS: lessons from Toronto (2003) (240)
State of Academic Knowledge on Toxicity and Biological Fate of Quantum Dots (2009) (239)
Global health ethics: the rationale for mutual caring (2003) (226)
‘Mind the gap’: science and ethics in nanotechnology (2003) (220)
A controlled trial of surgery for trachomatous trichiasis of the upper lid. (1992) (188)
Grand Challenges: Integrating Mental Health Care into the Non-Communicable Disease Agenda (2013) (158)
Grand Challenges in Global Mental Health: Integration in Research, Policy, and Practice (2013) (158)
Harnessing Genomics and Biotechnology to Improve Global Health Equity (2001) (155)
DNA databanks and consent: A suggested policy option involving an authorization model (2003) (155)
A proposed definition of regenerative medicine (2007) (152)
Bioethics for clinicians: 21. Islamic bioethics. (2001) (138)
Analysis of the distribution of HLA-B alleles in populations from five continents. (2000) (127)
Pharmacogenetics and geographical ancestry: implications for drug development and global health (2005) (121)
High mortality among recipients of bought living-unrelated donor kidneys (1990) (118)
Race and ancestry in biomedical research: exploring the challenges (2009) (118)
Innovative health service delivery models in low and middle income countries - what can we learn from the private sector? (2010) (106)
Chinese health biotech and the billion-patient market (2008) (103)
The Bellagio Task Force report on transplantation, bodily integrity, and the International Traffic in Organs. (1997) (98)
Chemical composition and tissue distribution of the human CDw44 glycoprotein. (1989) (92)
Incentives for Organ Donation: Proposed Standards for an Internationally Acceptable System (2012) (92)
LOCALIZATION OF MAJOR HISTOCOMPATIBILITY COMPLEX (HLA‐ABC AND DR) ANTIGENS IN 46 KIDNEYS: DIFFERENCES IN HLA‐DR STAINING OF TUBULES AMONG KIDNEYS (1983) (91)
India's health biotech sector at a crossroads (2007) (90)
The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR. (1983) (88)
Brain Death and Organ Transplantation: Cultural Bases of Medical Technology [and Comments and Reply] (1994) (84)
Ethics of Xenotransplantation: Animal Issues, Consent, and Likely Transformation of Transplant Ethics (1997) (83)
The scientific muscle of Brazil's health biotechnology (2004) (79)
ORAL VERSUS INTRAVENOUS HIGH-DOSE STEROID TREATMENT OF RENAL ALLOGRAFT REJECTION The Big Shot or Not? (1978) (78)
Global Health Challenges: The Need for an Expanded Discourse on Bioethics (2005) (76)
Conclusions: promoting biotechnology innovation in developing countries (2004) (74)
Brazilian health biotech—fostering crosstalk between public and private sectors (2008) (72)
Regenerative Medicine and the Developing World (2006) (70)
Cuba—innovation through synergy (2004) (68)
Whole Genome Scanning: Resolving Clinical Diagnosis and Management Amidst Complex Data (2009) (68)
Analysis of the distribution of HLA-A alleles in populations from five continents. (2000) (68)
Anomolous expression of HLA-DR antigens on human colorectal cancer cells. (1982) (66)
Theatre as a public engagement tool for health-policy development. (2006) (66)
Genomic medicine and developing countries: creating a room of their own (2008) (62)
The next steps for genomic medicine: challenges and opportunities for the developing world (2008) (61)
Indian biotechnology—rapidly evolving and industry led (2004) (58)
Harnessing Nanotechnology to Improve Global Equity (2005) (56)
Stem cell research and transplantation: science leading ethics. (2004) (55)
Scientific diasporas as an option for brain drain: re-circulating knowledge for development (2006) (55)
Regenerative medicine: New opportunities for developing countries (2006) (54)
Genomics, public health and developing countries: the case of the Mexican National Institute of Genomic Medicine (INMEGEN) (2008) (54)
The case for a regulated system of living kidney sales (2006) (49)
Grand Challenges in Global Health: The Ethical, Social and Cultural Program (2007) (48)
Priority setting for orphan drugs: an international comparison. (2011) (46)
Toward a New Era of Intellectual Property: From Confrontation to Negotiation - A Report by the International Expert Group on Biotechnology, Innovation and Intellectual Property (2008) (46)
Cultivating regenerative medicine innovation in China. (2010) (45)
Age‐specific reference levels of serum prostate‐specific antigen and prostate volume in healthy Arab men (2005) (44)
The use of race, ethnicity and ancestry in human genetic research (2011) (43)
Introducing New Technologies: Protecting Subjects of Surgical Innovation and Research (2003) (43)
Grand Challenges in Global Health: Engaging Civil Society Organizations in Biomedical Research in Developing Countries (2007) (43)
Introduction: promoting global health through biotechnology (2004) (43)
Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaborators (2012) (42)
South-South entrepreneurial collaboration in health biotech (2010) (42)
Health biotechnology in China—reawakening of a giant (2004) (41)
Marketing human organs: The autonomy paradox (1996) (41)
Ethics and commerce in live donor renal transplantation: classification of the issues. (1990) (38)
Scientific Diasporas (2006) (38)
Small but tenacious: South Africa's health biotech sector (2009) (38)
How can developing countries harness biotechnology to improve health? (2007) (37)
Biotechnology and the UN's Millennium Development Goals (2003) (37)
HLA antigens in Omani patients with vitiligo (1995) (37)
Public engagement on global health challenges (2008) (37)
South Africa—blazing a trail for African biotechnology (2004) (37)
Organ-specific IgM autoantibodies to liver, heart and brain in man: generalized occurrence and possible functional significance in normal individuals, and studies in patients with multiple sclerosis. (1981) (36)
Genomics—a global public good? (2003) (35)
Factors influencing agbiotech adoption and development in sub-Saharan Africa (2012) (35)
South Korean biotechnology—a rising industrial and scientific powerhouse (2004) (34)
Needed: models of biotechnology intellectual property. (2002) (31)
Stakeholder involvement in expensive drug recommendation decisions: an international perspective. (2012) (31)
Genomics knowledge and equity: a global public goods perspective of the patent system. (2004) (30)
Criteria to assess potential reverse innovations: opportunities for shared learning between high- and low-income countries (2017) (30)
South Africa: from species cradle to genomic applications (2008) (30)
Living-donor renal transplantation: Evidence-based justification for an ethical option (1997) (29)
Paid organ donation--the grey basket concept. (1998) (28)
Accelerating Health Product Innovation in sub-Saharan Africa (2007) (28)
A tough transition (2007) (28)
The Composition and properties of date proteins (1995) (28)
Lessons on Ethical Decision Making from the Bioscience Industry (2006) (27)
TDR Thirty Years On: Taking Stock and Envisioning the Future for the Special Programme for Research and Training in Tropical Diseases (2008) (27)
The three main monotheistic religions and gm food technology: an overview of perspectives (2009) (27)
Understanding and acting on the developmental origins of health and disease in Africa would improve health across generations (2017) (27)
From diversity to delivery: the case of the Indian Genome Variation initiative (2008) (27)
Science-based health innovation in sub-Saharan Africa (2010) (27)
The CNCDs and the NTDs: Blurring the Lines Dividing Noncommunicable and Communicable Chronic Diseases (2008) (27)
HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance (1997) (26)
Healthcare sustainability and the challenges of innovation to biopharmaceuticals in Canada. (2008) (26)
BioIndustry Ethics (2005) (26)
Legal and Ethical Approaches to Stem Cell and Cloning Research: A Comparative Analysis of Policies in Latin America, Asia, and Africa (2004) (26)
South Africa: from species cradle to genomic applications (2009) (26)
Biotechnology patenting takes off in developing countries (2006) (25)
Venture funding for science-based African health innovation (2010) (25)
The science of stem cells: ethical, legal and social issues. (2003) (25)
Declaration on mental health in Africa: moving to implementation (2014) (25)
Harnessing stem cells for health needs in India. (2008) (25)
Grand Challenges in Global Health: Ethical, Social, and Cultural Issues Based on Key Informant Perspectives (2007) (24)
Addressing Ethical, Social, and Cultural Issues in Global Health Research (2013) (24)
DEMONSTRATION WITH MONOCLONAL ANTIBODIES OF AN UNUSUAL MONONUCLEAR CELL INFILTRATE AND LOSS OF NORMAL EPITHELIAL MEMBRANE ANTIGENS IN HUMAN BREAST CARCINOMAS (1981) (23)
Health biotechnology publishing takes-off in developing countries (2006) (23)
Organ donation--world experience; the Middle East. (1991) (23)
The global alliance for chronic diseases. (2009) (23)
Innovative drugs and vaccines in China, India and Brazil (2012) (22)
Bidil: recontextualizing the race debate (2008) (22)
Prostate Cancer Risk: The Significance of Differences in Age Related Changes in Serum Conjugated and Unconjugated Steroid Hormone Concentrations Between Arab and Caucasian Men (2006) (22)
Science, Society, and the Supermarket: The Opportunities and Challenges of Nutrigenomics (2006) (22)
"Harnessing genomics to improve health in Africa" – an executive course to support genomics policy (2004) (22)
Biotechnology to improve health in developing countries -- a review. (2004) (21)
A Social Audit Model for Agro-biotechnology Initiatives in Developing Countries: Accounting for Ethical, Social, Cultural, and Commercialization Issues (2009) (21)
The unexamined assumptions of intellectual property: adopting an evaluative approach to patenting biotechnological innovation. (2004) (21)
Africa's largest long-lasting insecticide-treated net producer: lessons from A to Z Textiles (2010) (20)
Stagnant Health Technologies in Africa (2010) (20)
Animal-to-human organ transplants--a solution or a new problem? (1999) (20)
The composition and properties of jacalin, a lectin of diverse applications obtained from the jackfruit (Artocarpus heterophyllus) seeds. (1994) (20)
Strengthening the Role of Genomics in Global Health (2004) (20)
Ethical issues -- a Middle East perspective. (1989) (19)
Non-heart-beating donation: ten evidence-based ethical recommendations. (2004) (19)
A survey of South-North health biotech collaboration (2009) (19)
Graft avulsion: An unreported complication of axillofemoral bypass grafts (1978) (19)
Regenerative medicine in Brazil: small but innovative. (2010) (18)
HUGO Urges Genetic Benefit-Sharing (2001) (18)
Clinical ethics revisited: responses (2001) (18)
Transnational Knowledge Through Diaspora Networks (2006) (18)
Strangers, intimates, and altruism in organ donation. (2002) (18)
Culture and psychology in organ transplantation. (1998) (17)
Histocompatibility antigens in Omanis: Comparison with other Gulf populations and implications for disease association. (1999) (17)
Cultural and psychological dimensions of human organ transplantation. (1998) (17)
Rewarded Gifting and Rampant Commercialism in Perspective: Is There a Difference? (1991) (17)
Universal health care, genomic medicine and Thailand: investing in today and tomorrow (2008) (17)
Addressing conflicts of interest in Public Private Partnerships (2010) (17)
Shared Principles of Ethics for Infant and Young Child Nutrition in the Developing World (2010) (16)
Living nonrelated donor renal transplantation—A reappraisal (1990) (16)
The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan (2010) (16)
Implications of copy-number variation in the human genome: a time for questions (2006) (16)
Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians? (2006) (16)
Defining Conscience and Acting Conscientiously (2007) (16)
Putative role of serum insulin-like growth factor–1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men (2005) (15)
The human Thy-1 molecule. (1989) (15)
Science-based health innovation in Ghana: health entrepreneurs point the way to a new development path (2010) (15)
In Support of Academic Freedom (2007) (15)
Open Source Biotechnology Platforms for Global Health and Development: Two Case Studies (2011) (15)
Cyclosporine A versus cyclosporine G: a comparative study of survival, hepatotoxicity, nephrotoxicity, and splenic atrophy in BALB/c mice (1988) (15)
Moral presentation of genetics-based narratives for public understanding of genetic science and its implications (2006) (14)
Grand challenges in humanitarian aid (2018) (14)
Corporate social responsibility strategies aimed at the developing world: perspectives from bioscience companies in the industrialised world (2006) (14)
Human organ and tissue transplantation. Commentary (2005) (14)
Bridging the Genomics Divide (2003) (13)
Isolated injury to the intestine from blunt abdominal injury. (1984) (13)
The emergence of Egyptian biotechnology from generics (2004) (13)
Human genomic variation initiatives in emerging economies and developing countries (2008) (13)
Reimbursement, ‘rewarded gifting’, financial incentives and commercialism in living organ donation (1997) (13)
Xenotransplants: proceed with caution (1998) (13)
The Roles of a Bioethicist on an Organ Transplantation Service (2005) (12)
Identification of a novel 4 kDa immunoglobulin-A-binding peptide obtained by the limited proteolysis of jacalin. (1993) (12)
The role of the domestic private sector in developing countries for addressing local health needs (2006) (12)
Science-based health innovation in Uganda: creative strategies for applying research to development (2010) (12)
The future of replacement and restorative therapies: from organ transplantation to regenerative medicine. (2013) (12)
Nanotechnology, equity and global health (2021) (12)
The value of trust in biotech crop development: a case study of Bt cotton in Burkina Faso (2012) (11)
Developmental origins of health and disease in Africa-influencing early life. (2018) (11)
Paid organ procurement: pragmatic and ethical viewpoints. (2004) (11)
Chondroid syringoma of the nose: report of a case (1997) (11)
The Developmental Origins of Health and Disease and Sustainable Development Goals: mapping the way forward. (2017) (11)
The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries (2011) (11)
Living organ donation: time for a donor charter. (1996) (10)
ALTRUISM AND RECIPROCITY IN ORGAN DONATION: Compatible or Not? (2000) (10)
Science-based health innovation in Tanzania: bednets and a base for invention (2010) (10)
She Came, She Saw, She Sowed: Re-negotiating Gender-Responsive Priorities for Effective Development of Agricultural Biotechnology in Sub-Saharan Africa (2013) (10)
Rectal examination and acid phosphatase: evidence for persistence of a myth. (1981) (10)
Health biotechnology innovation on a global stage (2011) (10)
The response to the challenge of organ shortage in the Middle East region: a summary. (1997) (10)
Human-animal chimeras for vaccine development: an endangered species or opportunity for the developing world? (2010) (9)
Progress in Human Embryonic Stem Cell Research in the United States between 2001 and 2010 (2015) (9)
Realising the promise of genomics: exploring governance (2006) (9)
The binding of jacalin with rabbit immunoglobulin G. (1995) (9)
GENOMICS, BIOTECHNOLOGY AND GLOBAL HEALTH: THE WORK OF THE UNIVERSITY OF TORONTO JOINT CENTRE FOR BIOETHICS (2004) (9)
Characterization of HLA-B*3921 and confirmation of HLA-B*4415, two variant HLA-B alleles identified in the Omani population. (2000) (9)
Chronic Non-communicable Diseases as a Threat for All: Recent Global Initiatives. (2010) (9)
Rewarded gifting. (1992) (8)
The evolution of organ transplantation in the Middle East. (1999) (8)
"Harnessing genomics to improve health in India" – an executive course to support genomics policy (2004) (8)
Nonrelated donors and commercialism: a historical perspective. (1992) (8)
Quest for organ donors: development of transplant ethics. (1998) (8)
Ethical aspects of living donor kidney transplantation and recipient adherence to treatment. (2003) (7)
Genomics and Global Health - A Report of the Genomics Working Group of the Science and Technology Task Force of the United Nations Millennium Project (2004) (7)
The ethical, social, and cultural dimensions of screening for mental health in children and adolescents of the developing world (2020) (7)
HLA antigens in an Omani population with dilated cardiomyopathy. (1997) (7)
To Trust or Not to Trust: A Model for Effectively Governing Public-Private Partnerships (2013) (7)
Nutrients and Norms: Ethical Issues in Nutritional Genomics (2006) (7)
The science of stem cells: some implications for law and policy. (2002) (7)
Symptomatic response to ascorbic acid. (1996) (7)
Globetrotting firms: Canada's health biotechnology collaborations with developing countries (2009) (7)
Tiny technologies for the global good (2005) (7)
How Biodevelopment can Enhance Biosecurity (2009) (6)
North–South partnerships—a study of Canadian firms (2007) (6)
A survey of religious attitudes towards organ donation and transplantation (1997) (6)
Empirical Bioethics Research in the Developing World: When the ‘Is’ is Close to an ‘Ought’ (2009) (6)
Overcoming barriers to trust in agricultural biotechnology projects: a case study of Bt cowpea in Nigeria (2012) (6)
An overview of transplantation issues in the Middle East. (1998) (6)
Declaration on mental health in Africa: moving to implementation. (2014) (6)
Dust of Wonder, Dust of Doom: A Landscape of Nanotechnology, Nanoethics, and Sustainable Development (2016) (6)
Strategies for building trust with farmers: the case of Bt maize in South Africa (2012) (6)
A Survey of International Legal Instruments to Examine Their Effectiveness in Improving Global Health and in Realizing Health Rights (2013) (6)
An emerging transplant force--developing countries: Middle East and the Indian subcontinent. (1997) (5)
Prospects of organ sharing and strategies for increasing transplants in Asia. (1998) (5)
Do Patents Encourage or Inhibit Genomics as a Global Public Good? (2003) (5)
Building effective partnerships: the role of trust in the Virus Resistant Cassava for Africa project (2012) (5)
Innovation Cultures in Developing Countries: The Case of Health Biotechnology (2007) (5)
Science-based health innovation in Rwanda: unlocking the potential of a late bloomer (2010) (5)
Paid organ donation and organ commerce: continuing the ethical discourse. (2003) (5)
Brachial plexus palsy and spinal subarachnoid pneumatosis following trauma (1997) (5)
Applying genomics-related technologies for Africa's health needs. (2007) (5)
B-CELL ALLOANTIBODIES AND RENAL ALLOGRAFTS (1976) (5)
Biotechnology and global health (2011) (5)
Living nonrelated kidney transplantation: time to be taken seriously. (1999) (5)
Intra-consortium data sharing in multi-national, multi-institutional genomic studies: gaps and guidance (2009) (5)
Use of renal transplants from living donors (1999) (5)
South Mediterranean, Middle East, and subcontinent organ transplantation activity. (2001) (5)
Immunoglobulins, immunoglobulin G subclasses and complement in adult Omanis. (1997) (5)
Different Rhythms of Health Biotechnology Development in Brazil and Cuba (2006) (5)
Bridging the Genomics Divide. (Global Insights) (2003) (4)
The case for publicly funded research on the ethical, environmental, economic, legal and social issues raised by nanoscience and nanotechnology (NE3LS). (2004) (4)
Increasing human security through biotechnology (2006) (4)
Getting governance into genomics (2005) (4)
Developments in immunosuppressive therapy. (1995) (4)
The 20-year African biotech plan (2008) (4)
Cultural and societal issues in organ transplantation: examples from different cultures. (2000) (4)
Harnessing genomics to improve health in the Eastern Mediterranean Region – an executive course in genomics policy (2005) (4)
The World's Youngest Cadaveric Kidney Transplant: Medical, Surgical and Ethical Issues (2016) (4)
Building trust in biotechnology crops in light of the Arab Spring: a case study of Bt maize in Egypt (2012) (4)
Harmonized biosafety regulations are key to trust building in regional agbiotech partnerships: the case of the Bt cotton project in East Africa (2012) (4)
The grandest challenge : bringing life-saving science from lab to village (2011) (4)
Global Health and Global Health Ethics: Global health ethics: the rationale for mutual caring (2011) (4)
Leucocytosis is not a manifestation of rejection. (1977) (3)
Histologic changes in atrophic spleens of mice treated with cyclosporine A. (1987) (3)
Emerging Science, Emerging Ethical Issues: Who Should Fund Innate Alloimmunity-suppressing Drugs ? (2008) (3)
The World Health Organization resolution on human organ transplantation: will it result in action? (2005) (3)
Ethical issues in molecular medicine of relevance to surgeons. (2004) (3)
Avian influenza and pandemics. (2005) (3)
Ethical issues--a Middle East perspective. (1989) (3)
Beyond GM Foods: Genomics, Biotechnology and Global Health Equity (2005) (2)
Xenotransplantation: informed consent/contract and patient surveillance. (1999) (2)
A comparison of PSA density among Arabs, USA whites and the Japanese (2003) (2)
Somatic cell nuclear transfer—how science outpaces the law (2003) (2)
Refugees in the eastern Mediterranean region (2015) (2)
Admixture mapping: from paradigms of race and ethnicity to population history (2010) (2)
Advancing the DOHaD agenda in Africa (2018) (2)
MERCK: STAYING THE COURSE (2005) (2)
Xenotransplantation: recent scientific developments and continuing ethical discourse. (2003) (2)
Erratum: South-South entrepreneurial collaboration in health biotech (2010) (2)
The case for using living non-related donors to alleviate the world wide shortage of cadaver kidneys for transplantation. (1991) (2)
Age and dose dependence of cyclosporine G nephrotoxicity in BALB/c mice. (1987) (2)
Current Practice and the Legal, Ethical, and Religious Status of Post Mortem Organ Donation in the Islamic World (1991) (2)
Xenotransplantation and cloning: working with the World Health Organization to develop ethical guiding principles. (2000) (2)
Choosing Risk-Benefit Analysis or Precautionary Principle as Our Approach to Clinical Xenotransplantation (2001) (2)
Ethics in Transplantation: Allotransplantation and Xenotransplantation (2008) (2)
DIVERSA INC.: ETHICAL ISSUES IN BIOPROSPECTING PARTNERSHIPS (2005) (2)
Enabling knowledge societies in developing countries: the example of genomics (2006) (2)
AFFYMETRIX, INC.: USING CORPORATE ETHICS ADVICE (2005) (2)
The IVI ’ s innovative approach to closing the gap between vaccines for industrialized and developing countries (2010) (2)
Societal issues in organ transplantation. (1998) (1)
SCIONA LTD.: A PIONEER IN NUTRIGENOMICS: THE PATH TO CONSUMER ACCEPTANCE (2005) (1)
Building trust in biotechnology crops in light of the Arab Spring: a case study of Bt maize in Egypt (2012) (1)
The Cambridge Textbook of Bioethics: Regenerative medicine (2008) (1)
Xenotransplantation: Science, Risk and International Regulatory Efforts (1999) (1)
Health in Transition: Translating developmental origins of health and disease science to improve future health in Africa (2020) (1)
Building effective partnerships: the role of trust in the Virus Resistant Cassava for Africa project (2012) (1)
The ELSI Genetics Regulatory Resource Kit: A Tool for Policymakers in Developing Countries (2004) (1)
Genomic Applications in Medicine and Health in India (2012) (1)
The value of trust in biotech crop development: a case study of Bt cotton in Burkina Faso (2012) (1)
Harnessing Genomics for Global Health: The Role of Higher Education (2005) (1)
. The Genomic Research and Health Applications in South Africa1,2 (2012) (1)
Factors responsible for elimination of potential kidney donors in a living-related donor kidney transplant program. (1992) (1)
International Society for Developmental Origins of Health and Disease’s work at the Stellenbosch Institute for Advanced Study (2020) (1)
Tumour markers in clinical practice : concepts and applications (1987) (1)
Overcoming barriers to trust in agricultural biotechnology projects: a case study of Bt cowpea in Nigeria (2012) (1)
Creating a pandemic of health: Big ideas for a new initiative on global health equity and innovation (2015) (1)
Immunopathological changes in the spleen of BALB/c mice treated with either cyclosporine A or cyclosporine G. (1989) (1)
Maturation of immunoglobulin-A binding proteins in the seeds of jackfruit. (1995) (1)
Living-organ donation: time for a donor charter. (1994) (1)
The Cambridge Textbook of Bioethics: Organ transplantation (2008) (1)
The Israeli-Palestinian Science Organization (2007) (1)
GENZYME: PUTTING PATIENTS FIRST (2005) (1)
Beyond the Georgetown Mantra (2000) (1)
Identification and characterisation of two glycoproteins of molecular weights 60 and 180 kd from human multigravid placenta having strong in vitro immunosuppressive activity. (1992) (1)
Vision of a personal genomics future (2010) (1)
Erratum: Factors influencing agbiotech adoption and development in sub-Saharan Africa (2012) (1)
Trait stacking for biotech crops: an essential consideration for agbiotech development projects for building trust (2012) (1)
Impact of renal transplantation on liver disease of diverse etiology. (1992) (1)
MAXIM PHARMACEUTICALS (A): INTERNAL AND EXTERNAL DIALOGUES (2005) (0)
Nutritional Genomics: Opportunities and Challenges (2006) (0)
Mapping of developmental origins of health and disease to ‘Sustainable Development Goals’ and implications for public health in Africa (2020) (0)
INTERLEUKIN GENETICS AND ALTICOR: AN UNLIKELY PARTNERSHIP (2005) (0)
Changes in circulating serum adrenal c19-steroids among arabs and caucasians: A probable explanation for differences in incidence of prostate cancer (2003) (0)
MILLENNIUM PHARMACEUTICALS, INC.: CREATING AND SUSTAINING CORPORATE VALUES (2005) (0)
Scrotal Cancer - a notifiable occupational disease. (1981) (0)
Herniation Through an Iatrogenic Ilial Bone Defect (1984) (0)
La négligence médicale. Discussion (1996) (0)
Letter: B-cell alloantibodies and renal allografts. (1976) (0)
Rectal examination and acid phosphatase (1981) (0)
Genetics and biotechnology (2008) (0)
Debateconflicts of interest in Public Private Partnerships (2010) (0)
The Ethics of Nutrigenomic Tests and Information (2006) (0)
A Tool for Policymakers in Developing Countries (2004) (0)
The Science of Nutrigenomics and Nutrigenetics (2006) (0)
A survey of entrepreneurial collaborations among health biotech firms in developing countries reveals a surprisingly high level of collaboration but a lack of emphasis on new or improved health biotech products and processes. (2010) (0)
TGN BIOTECH: A START-UP WITH ETHICAL ROOTS (2005) (0)
BMC Public Health Correspondence Public engagement on global health challenges (2008) (0)
The plain X-ray in the diagnosis of the acute abdomen: A surgical handbook with notes on clinical presentation and differential diagnosis, (1971) (0)
. Genomics for Universal Healthcare in Thailand1,2 (2012) (0)
Authors' Reply (2006) (0)
CONCLUSION: LESSONS FOR COMPANIES AND FUTURE ISSUES (2005) (0)
Omani experience with a heterogeneous group of kidney transplant recipients over a 10-year period. (1993) (0)
Invited Commentary (2003) (0)
Suppression of in vitro lymphocyte reactivity to PHA by lysates from human placentae: lack of correlation with gravida number. (1992) (0)
Rectal examination and acid phosphatase. (1981) (0)
Platforms for Global Health and Development : Two Case Studies (2011) (0)
Strategies for building trust with farmers: the case of Bt maize in South Africa (2012) (0)
THE COMPOSITlON AND PROPERTIS OF JACALIN,A LIjCIlN OF DIVERSE APPLICATIONS OBTAINED FROM THE JACKFRUIT (ARTWARPUS HmOPHYLUB SEEDS (1994) (0)
Urges Genetic Benefit-Sharing HUGO Ethics Committee : Bartha Maria Knoppers ( Chair ) (2001) (0)
Laparoscopic surgery at Sultan Qaboos University Hospital. (2000) (0)
Alternatives for Nutrigenomic Service Delivery (2006) (0)
Book review: Regenerative medicine applications in organ transplantation (ISBN: 9780123985231) (2015) (0)
Chemical weapons: safe until 2004? (1995) (0)
Trait stacking for biotech crops: an essential consideration for agbiotech development projects for building trust (2012) (0)
Nutrigenomics: Justice, Equity, and Access (2006) (0)
Announcement / Erratum (2008) (0)
Grand challenges in humanitarian aid (2018) (0)
PHARMASNPS INC.: CREATING AN ETHICS ADVISORY BOARD (2005) (0)
What Islamic Bioethics Offers to Global Bioethics (2017) (0)
MONSANTO COMPANY: BIO-AGRICULTURE PIONEER (2005) (0)
for mutual caring (2016) (0)
Harnessing Advanced Technologies for Global Health Equity (2008) (0)
Vacation reading (2010) (0)
Ethical, Social, and Policy Issues: Introduction (2003) (0)
NOVO NORDISK: THE TRIPLE BOTTOM LINE (2005) (0)
Editorial: Societal Issues in Organ Transplantation (1998) (0)
Harmonized biosafety regulations are key to trust building in regional agbiotech partnerships: the case of the Bt cotton project in East Africa (2012) (0)
Debatechimeras for vaccine development: an endangered species or opportunity for the developing world? (2010) (0)
An environmental survey of existing undergraduate global health programs (2016) (0)
Authors' reply [4] (2006) (0)
Science and society - Universal health care, genomic medicine and Thailand: investing in today and tomorrow (2008) (0)
She Came, She Saw, She Sowed: Re-negotiating Gender-Responsive Priorities for Effective Development of Agricultural Biotechnology in Sub-Saharan Africa (2012) (0)
Pharmacogenetics, pharmacogenomics and population admixture: implications for drug development and prescription (2005) (0)
The Cambridge Textbook of Bioethics: Islamic bioethics (2008) (0)
PIPELINE BIOTECH A/S: COMPETING REGULATORY REGIMES FOR LABORATORY ANIMAL EXPERIMENTS (2005) (0)
Nutrigenomics and the Regulation of Health Claims for Foods and Drugs (2006) (0)
Lifeline (2000) (0)
Healthcare Venture Capital for Africa—Response (2011) (0)
Regenerative Medicine and the Developing (2006) (0)
Science-based health innovation in (2010) (0)
Clinical translation of neuro-regenerative medicine in India: A study on barriers and enabling strategies (2013) (0)
662 FOCUSING RESEARCH TO ENSURE IMPACT: THE GLOBAL ALLIANCE FOR CHRONIC DISEASE (2012) (0)

This paper list is powered by the following services:

Other Resources About Abdallah Daar

en.wikipedia.org

What Schools Are Affiliated With Abdallah Daar?

Abdallah Daar is affiliated with the following schools:

Abdallah Daar's Academic­Influence.com Rankings

Why Is Abdallah Daar Influential?

Abdallah Daar's Published Works

Published Works

Other Resources About Abdallah Daar

What Schools Are Affiliated With Abdallah Daar?

Abdallah Daar's AcademicInfluence.com Rankings